Cointime

AcuraStem

company

About

AcuraStem harnesses human, patient-specific in vitro cell models and assays to develop cures and improve diagnoses in disorders of the CNS.

  • 11 - 50

Highlights

Total Funding Amount
$2M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Grant
Last Funding Money Raised
$1M
Industries
Artificial Intelligence,Biotechnology,Health Care,Medical,Neuroscience
Founded date
Jan 1, 2016
Number Of Employee
11 - 50
Operating Status
Active

AcuraStem is a startup company that was formed in 2016 to create an innovative precision medicine platform. They are a team of PhDs, professors, tech entrepreneurs, and successful drug company veterans employing the latest scientific breakthroughs to address one of the most challenging, but they believe tractable, health problems of their time —Amyotrophic Lateral Sclerosis (ALS).

AcuraStem harnesses advanced cellular reprogramming and artificial intelligence technologies to transform the standard of care for neurodegenerative diseases through patient-specific treatment.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$2M
AcuraStem has raised a total of $2M in funding over 2 rounds. Their latest funding was raised on May 25, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 25, 2021 Grant $1M 1 Congressionally Directed Medical Research Programs — Detail
Nov 8, 2019 Convertable Note $1M 1 Keiretsu Forum — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
AcuraStem is funded by 2 investors. Congressionally Directed Medical Research Programs and Keiretsu Forum are the most recent investors.
Investor Name Lead Investor Funding Round
Congressionally Directed Medical Research Programs Yes Grant
Keiretsu Forum Yes Convertable Note
Cointime
เนื้อหา
บริษัท